Anacor Pharma Cash Flow - Quarterly (NASDAQ:ANAC)

Add to My Stocks
$99.2 $0 (0%) ANAC stock closing price Jun 24, 2016 (Closing)

The cash flow statement is one of the reports a publicly traded company like Anacor Pharma needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Anacor Pharma profits and Anacor Pharma debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Anacor Pharma stock analysis. Anacor Pharma generated $-9.58M cash from operating activities in till this quarter of 2016 Q1. Anacor Pharma saw a outflow of $-22.07M from investing activities till 2016 Q1.

View and download details of Anacor Pharma cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q12015 Q4
Net Income Cash Flow
-16.14M-61.24M
Depreciation Depletion Amortization Cash-Flow1.19M5.58M
Net Increase (Decrease) in Assets Liabilities--19.06M
Cash From (used in) Discontinued Operations--
Other Adjustments Net5.33M18.46M
Net Cash from (used by) Operating Activities
-9.58M-56.27M
Increase (Decrease) in Prop Plant And Equipment-0.07M-0.81M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments-22.57M82.91M
Other Cash Inflow (Outflow) from Investment Activities--
Net Cash from (used by) Investment Activities
-22.07M83.01M
Issuance (Purchase) of Equity Shares--
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities2.95M10.94M
Net Cash from (used by) Financing Activities
2.95M10.94M
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
-28.7M37.68M
Cash & Equivalents at Beginning of Year47.3M9.32M
Cash & Equivalents at Year End24.97M53.67M
All figures in USD. M: Millions of USD, B: Billions of USD.

Anacor Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Anacor Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Anacor Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Anacor Pharma stock price movement.
  • Cash Flow from operating activities: Anacor Pharma reported a negative operating cash flow of $-9.58M till 2016 Q1 and has seen an increase from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-22.07M for ANAC stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Anacor Pharma and its owners and creditors and was $2.95M till 2016 Q1. Financing activities allow a company to raise capital, and repay bondholders.

Quarterly Cash Flow Statements For Anacor Pharmaceuticals Inc Peers

Ariad Pharma cash flow, Cidara Therapeutics cash flow, NOVAN INC cash flow, Scynexis cash flow